Carnegie Investment Counsel’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$547K Sell
11,072
-247
-2% -$12.5K 0.01% 381
2026
Q1
$604K Sell
11,319
-2,272
-17% -$133K 0.01% 388
2025
Q4
$845K Sell
13,591
-139
-1% -$8.58K 0.02% 344
2025
Q3
$825K Hold
13,730
0.02% 335
2025
Q2
$860K Buy
13,730
+75
+0.5% +$4.51K 0.02% 321
2025
Q1
$756K Sell
13,655
-25
-0.2% -$1.55K 0.02% 317
2024
Q4
$798K Sell
13,680
-900
-6% -$53.5K 0.02% 293
2024
Q3
$863K Hold
14,580
0.03% 285
2024
Q2
$817K Sell
14,580
-45
-0.3% -$2.52K 0.03% 287
2024
Q1
$857K Sell
14,625
-353
-2% -$19.9K 0.03% 302
2023
Q4
$808K Sell
14,978
-1,755
-10% -$85.7K 0.03% 303
2023
Q3
$812K Sell
16,733
-299
-2% -$15.9K 0.03% 290
2023
Q2
$962K Sell
17,032
-49
-0.3% -$2.7K 0.04% 279
2023
Q1
$922K Sell
17,081
-3,450
-17% -$184K 0.04% 287
2022
Q4
$1.08M Sell
20,531
-1,777
-8% -$90.2K 0.05% 272
2022
Q3
$1.05M Sell
22,308
-914
-4% -$47.4K 0.05% 258
2022
Q2
$1.17M Sell
23,222
-4,128
-15% -$225K 0.05% 242
2022
Q1
$1.67M Sell
27,350
-45
-0.2% -$2.68K 0.06% 214
2021
Q4
$1.8M Buy
27,395
+1,672
+7% +$107K 0.06% 216
2021
Q3
$1.61M Buy
25,723
+1,093
+4% +$69.7K 0.06% 204
2021
Q2
$1.48M Buy
24,630
+4,146
+20% +$240K 0.06% 219
2021
Q1
$1.13M Sell
20,484
-1,278
-6% -$70.9K 0.05% 237
2020
Q4
$1.19M Sell
21,762
-156
-0.7% -$8.15K 0.05% 222
2020
Q3
$1.09M Sell
21,918
-1,194
-5% -$57.8K 0.06% 208
2020
Q2
$1.01M Buy
23,112
+24
+0.1% +$1.03K 0.06% 214
2020
Q1
$863K Sell
23,088
-150
-0.6% -$6.32K 0.06% 209
2019
Q4
$1.02M Sell
23,238
-750
-3% -$31.5K 0.06% 221
2019
Q3
$988K Hold
23,988
0.06% 219
2019
Q2
$962K Sell
23,988
-24
-0.1% -$908 0.06% 221
2019
Q1
$927K Sell
24,012
-60
-0.2% -$2.18K 0.06% 221
2018
Q4
$802K Sell
24,072
-14,280
-37% -$494K 0.07% 205
2018
Q3
$1.35M Buy
38,352
+14,280
+59% +$507K 0.11% 175
2018
Q2
$839K Hold
24,072
0.06% 219
2018
Q1
$791K Sell
24,072
-90
-0.4% -$2.77K 0.07% 209
2017
Q4
$730K Sell
24,162
-2,490
-9% -$71.8K 0.06% 232
2017
Q3
$768K Sell
26,652
-2,310
-8% -$63.9K 0.09% 208
2017
Q2
$788K Sell
28,962
-4,260
-13% -$113K 0.1% 197
2017
Q1
$872K Sell
33,222
-1,860
-5% -$45.1K 0.11% 184
2016
Q4
$786K Sell
35,082
-750
-2% -$17K 0.1% 181
2016
Q3
$840K Sell
35,832
-1,800
-5% -$42.8K 0.12% 174
2016
Q2
$888K Buy
37,632
+468
+1% +$10.1K 0.13% 174
2016
Q1
$756K Sell
37,164
-2,436
-6% -$47.3K 0.12% 179
2015
Q4
$760K Sell
39,600
-240
-0.6% -$4.8K 0.13% 165
2015
Q3
$775K Sell
39,840
-420
-1% -$8.44K 0.13% 160
2015
Q2
$803K Buy
40,260
+2,010
+5% +$40.2K 0.14% 158
2015
Q1
$772K Buy
38,250
+17,490
+84% +$341K 0.13% 156
2014
Q4
$402K Buy
20,760
+3,510
+20% +$63.3K 0.08% 204
2014
Q3
$286K Sell
17,250
-2,400
-12% -$40.8K 0.06% 241
2014
Q2
$334K Sell
19,650
-450
-2% -$7.36K 0.08% 179
2014
Q1
$331K Hold
20,100
0.09% 168
2013
Q4
$311K Sell
20,100
-1,200
-6% -$17.9K 0.08% 174
2013
Q3
$301K Sell
21,300
-600
-3% -$8.25K 0.09% 169
2013
Q2
$287K Buy
+21,900
New +$284K 0.09% 163

Other funds holding IHI

Carnegie Investment Counsel's IHI Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its iShares US Medical Devices ETF (IHI) stake by 2.2% in Q2 2026, selling an estimated $12.5K and leaving 11,072 shares worth $547K. The position accounts for 0.01% of the portfolio, ranked #381.

Carnegie Investment Counsel first reported a position in IHI in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.8M in Q4 2021. 296 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Carnegie Investment Counsel held 11,072 shares of iShares US Medical Devices ETF worth $547K as of Q2 2026.
  • Carnegie Investment Counsel sold 247 iShares US Medical Devices ETF shares in Q2 2026, an estimated $12.5K.
  • iShares US Medical Devices ETF made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #381 holding.
  • Carnegie Investment Counsel first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 53 quarters since.
  • Carnegie Investment Counsel's iShares US Medical Devices ETF position peaked at $1.8M in Q4 2021.
  • 296 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.